Medicare Enrolled
Dr. Abdallah Dlewati, M.D.
Endocrinology · Flint, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dlewati from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dlewati?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dlewati
Dr. Abdallah Dlewati is an endocrinology specialist in Flint, MI, with 18 years of NPI registration. Based on federal Medicare data, Dr. Dlewati performed 2,872 Medicare services across 1,369 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dlewati received a total of $8,998 from 69 pharmaceutical and/or device companies across 512 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dlewati is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 9% volume in MI
$8,998 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,872
Medicare services
Top 9% in MI for endocrinology
1,369
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~160 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
860 | $96 | $175 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
781 | $65 | $112 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
452 | $42 | $70 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
312 | $3 | $5 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
211 | $108 | $200 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
151 | $28 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
72 | $124 | $285 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $135 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,998
Total received (2018-2024)
Avg $1,285/year across 7 years
Top 23% in MI for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
512
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,998 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,490
2023
$1,455
2022
$1,460
2021
$1,614
2020
$846
2019
$1,248
2018
$886
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$234
Novo Nordisk Inc
$119
Amgen Inc.
$118
SANOFI-AVENTIS U.S. LLC
$90
Abbott Laboratories
$79
Astellas Pharma US Inc
$78
Boehringer Ingelheim Pharmaceuticals, Inc.
$71
ABBVIE INC.
$70
Antares Pharma, Inc.
$46
Alexion Pharmaceuticals, Inc.
$46
Corcept Therapeutics
$44
Esperion Therapeutics, Inc.
$43
Radius Health, Inc.
$43
Alvogen Inc
$39
Insulet Corporation
$38
PFIZER INC.
$36
BETA BIONICS, INC.
$28
EVOKE PHARMA, INC.
$23
Bayer Healthcare Pharmaceuticals Inc.
$23
Ascensia Diabetes Care Us Inc.
$21
Amphastar Pharmaceuticals, Inc.
$21
Amneal Pharmaceuticals LLC
$21
Xeris Pharmaceuticals, Inc.
$21
Verity Pharmaceuticals Inc.
$20
Kyowa Kirin, Inc.
$20
Dexcom, Inc.
$20
RECORDATI_RARE_DISEASES_INC.
$19
Acella Pharmaceuticals, LLC
$17
CeQur Corporation
$16
Medtronic, Inc.
$16
TheracosBio, LLC
$11
Top 3 companies account for 31.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$887
Lilly USA, LLC
$752
Abbott Laboratories
$612
SANOFI-AVENTIS U.S. LLC
$531
Corcept Therapeutics
$449
Amgen Inc.
$392
Radius Health, Inc.
$324
Boehringer Ingelheim Pharmaceuticals, Inc.
$310
Merck Sharp & Dohme Corporation
$286
Antares Pharma, Inc.
$258
Xeris Pharmaceuticals, Inc.
$257
Amarin Pharma Inc.
$219
Dexcom, Inc.
$195
Amneal Pharmaceuticals LLC
$174
Medtronic, Inc.
$167
Insulet Corporation
$165
Supernus Pharmaceuticals, Inc.
$165
AstraZeneca Pharmaceuticals LP
$160
Alexion Pharmaceuticals, Inc.
$136
Ipsen Biopharmaceuticals, Inc
$134
Esperion Therapeutics, Inc.
$133
Medtronic MiniMed, Inc.
$124
AbbVie Inc.
$117
LifeScan, Inc.
$99
ABBVIE INC.
$92
Becton, Dickinson and Company
$92
PFIZER INC.
$82
IBSA Pharma Inc.
$82
Horizon Therapeutics plc
$81
Alvogen Inc
$79
LIFESCAN, INC.
$78
Astellas Pharma US Inc
$78
AbbVie, Inc.
$74
Bayer Healthcare Pharmaceuticals Inc.
$69
Janssen Pharmaceuticals, Inc
$58
Bayer HealthCare Pharmaceuticals Inc.
$57
Amryt Pharma Holdings Ltd
$52
CeQur Corporation
$47
Embecta Corp.
$47
Clarus Therapeutics Inc.
$46
Merck Sharp & Dohme LLC
$44
Currax Pharmaceuticals LLC
$44
RECORDATI_RARE_DISEASES_INC.
$43
Zealand Pharma US, Inc.
$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$43
EVOKE PHARMA, INC.
$40
Kyowa Kirin, Inc.
$39
MannKind Corporation
$37
Nevro Corp.
$36
Acerus Pharmaceuticals Corporation
$35
Ferring Pharmaceuticals Inc.
$35
Evoke Pharma, Inc.
$34
Kowa Pharmaceuticals America, Inc.
$34
Shire North American Group Inc
$31
Aytu BioScience, Inc
$30
Companion Medical, Inc.
$28
BETA BIONICS, INC.
$28
Gilead Sciences, Inc.
$27
Valeritas, Inc.
$24
Ascensia Diabetes Care Us Inc.
$21
Amphastar Pharmaceuticals, Inc.
$21
Verity Pharmaceuticals Inc.
$20
Ultragenyx Pharmaceutical Inc.
$18
Acella Pharmaceuticals, LLC
$17
Orexigen Therapeutics, Inc.
$17
Nalpropion Pharmaceuticals LLC
$15
Tolmar, Inc.
$13
Takeda Pharmaceuticals U.S.A., Inc.
$12
TheracosBio, LLC
$11
Top 3 companies account for 25.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · Brenzavvy · CONTRAVE · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GIMOTI · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LANTUS · Livalo · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid 60 · Natesto · Norditropin · ONETOUCH VERIO FLEX · ONETOUCH VERIO REFLECT · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · Prolia · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Somatuline Depot · Strensiq · Synthroid · TEPEZZA · TERIPARATIDE · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZOMACTON · iLet Bionic Pancreas
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
6
Per 100K population
1.5
County median income
$60,673
Nearest hospital
MCLAREN FLINT
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dlewati is a clinical cardiology specialist, with above-average Medicare volume (top 9% in MI), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dlewati experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dlewati performed 860 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dlewati receive payments from pharmaceutical companies?
Yes. Dr. Dlewati received a total of $8,998 from 69 companies across 512 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dlewati's costs compare to other endocrinologists in Flint?
Dr. Dlewati's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dlewati) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Flint
Browse endocrinologists in Flint ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MI
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MI
Which MI endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology